Dr.MEENAKASHI DHADWAL
Cases of pterygium with no other ocular abnormality and with no systemic disorders were photographically graded. Ten cases of grade 3 and 11 cases of grade 2 pterygie were administered sub-conjunctival intra-lesional injection of 2.5mg/0.1ml of bevacizumab. Cases were taken on day 7, 28 and day 90 along with complete ocular examination and general physical examination. The pterygium vascularity, size and thickness were assessed by anterior segment photography. Any Ophthalmic or systemic side effects were noted. Of the ten cases of Grade 3 pterygium, 08 (80%) showed a decrease in vascularity with half of them graded as 2 and the remaining half as grade 1. Of the 11 cases of Grade 2 pterygium at baseline, 05 (45%) cases changed to grade I by day 90. There was also a decrease in redness, itching, watering, and irritation. This study showed that sub-conjunctival injection of bevacizumab was safe and efficacious in treatment of grade 2 & 3 pterygium.
Leave a Comment